LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma.

J Clin Lab Anal · 2023 · PMC9833968 · PMID 36572999

Europe PMC DOI

hedged sentence

0.3800

closest p · 7.6× alpha

0.3800

boldest claim

The sentences

showed a trendp = 0.38not close (p > 0.1)

According to Figure 3A,D , patients with low LIPG expression showed a trend of better OS ( p = 0.38 and p = 0.13).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.